Clinical research on antiangiogenic therapy.


A promising novel target for anti-cancer therapy is the tumour vasculature. Both primary tumour growth and the formation of metastasis depend on the establishment of new blood vessels from preexisting ones, a process called angiogenesis. Inhibition of angiogenesis and targeting of the tumour vasculature are highly effective in controlling tumour growth. Several natural and synthetic compounds have been developed and are currently tested in pre-clinical and clinical studies. This review intends to provide an overview of agents with antiangiogenic activity and the early clinical experience with these drugs.

More about this publication

Pharmacological research
  • Volume 37
  • Issue nr. 1
  • Pages 1-16
  • Publication date 01-01-1998

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.